Global Viral Gastroenteritis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Indication;

Watery Diarrhea, Vomiting, Abdominal Cramps And Pain and Others.

By End User;

Hospital, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn684427477 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Viral Gastroenteritis Market (USD Million), 2021 - 2031

In the year 2024, the Global Viral Gastroenteritis Market was valued at USD 6,732.39 million. The size of this market is expected to increase to USD 8,870.11 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.0%.

The global viral gastroenteritis market, measured in USD million, has witnessed a notable trajectory from 2021 to 2031. This period has been marked by several factors influencing the market dynamics, including advancements in diagnostic techniques, changes in healthcare infrastructure, and evolving treatment approaches.

In recent years, there has been a growing awareness regarding the prevalence and impact of viral gastroenteritis, leading to increased investments in research and development aimed at better understanding the disease and improving treatment outcomes. Moreover, the emergence of novel therapies and antiviral agents targeted at specific viral strains responsible for gastroenteritis has further propelled market growth.

The market has also been shaped by factors such as changing demographics, globalization, and environmental factors that contribute to the spread of viral gastroenteritis. As healthcare systems strive to enhance their preparedness and response to infectious diseases, the demand for effective diagnostics, therapeutics, and preventive measures against viral gastroenteritis is expected to drive market expansion in the forecast period. Overall, the global viral gastroenteritis market is poised for continued growth, driven by ongoing efforts to address the burden of this infectious disease on a global scale.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Indication
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Viral Gastroenteritis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Awareness
        2. Research Advancements
        3. Rising Prevalence
      2. Restraints
        1. Regulatory Challenges
        2. Economic Constraints
        3. Infrastructure Gaps
      3. Opportunities
        1. Emerging Markets
        2. Tech Innovations
        3. Collaborative Efforts
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Global Viral Gastroenteritis Market, By Indication, 2021 - 2031 (USD Million)
      1. Watery Diarrhea
      2. Vomiting
      3. Abdominal Cramps And Pain
      4. Others
    2. Global Viral Gastroenteritis Market, By End User, 2021 - 2031 (USD Million)
      1. Hospital
      2. Clinics
      3. Pharmaceutical Companies
      4. Diagnostic Centers
      5. Ambulatory Care Centers
      6. Others
    3. Global Viral Gastroenteritis Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Valeant Pharmaceuticals
      2. Janssen Biotech Inc.
      3. Takeda Pharmaceutical
      4. Abbott
      5. Bayer AG
  7. Analyst Views
  8. Future Outlook of the Market